Audience point of view
You may also be interested in:
European Commission reports show misuse of divisionals can in itself contravene EU law
In November last year, I was interviewed about the European Commission’s €462.6 million fine against pharmaceutical giant Teva and
IP Enforcement Strategies: Combating Counterfeiting in Southeast Asia and China
Counterfeiting remains among the most significant threats to intellectual property rights globally, particularly in Southeast Asia and China. These
How foreign applicants can take advantage of China’s updated patent regime
China implemented the fourth amendment to its Patent Law, which came into effect on 1 July 2021. The amended